Taysha Gene Therapies, Inc. (NASDAQ:TSHA) appears in 190 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 2,278,268 | 13.92% | $0.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 21,700,000 | 100.00% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | -1,229,085 | -6.37% | $0.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 0 | 8,250,000 | 150.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | 143,609 | 2.66% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | -7,955,994 | -32.67% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | -884,824 | -8.03% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 5,000 | 100.00% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 309,031 | 2.31% | $0.00 |
| Octagon Capital Advisors LP | 31 Dec, 2025 | 0 | -207,589 | -2.29% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -1,065,046 | -7.30% | $0.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 0 | 2,637,524 | 49.82% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 418,192 | 3.25% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 2,155,938 | 76.03% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 3,553,619 | 49.11% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | -3,462,788 | -47.23% | $0.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 0 | 300,000 | 10.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 212,510 | 4.11% | $0.00 |
| B Group, Inc. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |